1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Affordable Care Act, health insurance coverage, and cancer outcomes
    Journal Article

    Mailankody, S.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR) T cells genetically engineered to deliver IL-12 to the tumor microenvironment in ovarian cancer
    Meeting Abstract

    Yeku, O. O.; Purdon, T.; Spriggs, D. R.; Brentjens, R. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • SMAD4 loss in colorectal cancer: Correlation with recurrence, chemoresistance, and immune infiltrate
    Meeting Abstract

    Wasserman, I.; Lee, L. H.; Shia, J. R.; Wu, C.; Chen, X.; Guillem, J. G.; Paty, P.; Weiser, M. R.; Nash, G. M.; Temple, L. K. F.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • The immunomodulatory protein Dickkopf-1 (DKK1) defines a non-neuroendocrine subtype of metastatic castration-resistant prostate cancer (mCRPC) with low AR and low PSA expression
    Meeting Abstract

    Wise, D.; Armenia, J.; Chen, Y.; Nelson, P.; Schultz, N.; Sawyers, C. L.; Scher, H. I.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • The next generation of quality improvement at MSK: Turning chemotherapy process delays into chemo express
    Meeting Abstract

    Tota, J.; Levine, K.; Gordon, J.; Baldwin, A.; Wald, J.; Salvaggio, R.; Lee-Teh, M.; Freeswick, S.; O'Cearbhaill, R.; Reidy, D. L.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Treatment patterns and characteristics of acute promyelocytic leukemia (APL) patients receiving arsenic trioxide (ATO) therapy in a real-world setting
    Meeting Abstract

    Tang, B.; Gabriel, S.; Zhou, J.; Pathak, A. K.; Irwin, D.; Riehle, E.; Lo-Coco, F.; Tallman, M. S.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Enasidenib in mutant-IDH2 relapsed or refractory acute myeloid leukemia (R/R AML): Results of a phase I dose-escalation and expansion study
    Meeting Abstract

    Stein, E. M.; Dinardo, C. D.; Pollyea, D. A.; Fathi, A. T.; Roboz, G. J.; Altman, J. K.; Stone, R. M.; Flinn, I.; Kantarjian, H. M.; Collins, R.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Effect of cytarabine/anthracycline/crenolanib induction on minimal residual disease (MRD) in newly diagnosed FLT3 mutant AML
    Meeting Abstract

    Stone, R. M.; Collins, R.; Tallman, M. S.; Walter, R. B.; Karanes, C.; Patel, P. A.; Vusirikala, M.; Coombs, C. C.; Olson, G.; Jain, V. K.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • H3B-8800-G0001-101: A first in human phase I study of a splicing modulator in patients with advanced myeloid malignancies
    Meeting Abstract

    Steensma, D. P.; Maris, M. B.; Yang, J.; Donnellan, W. B.; Brunner, A. M.; McMasters, M.; Greenberg, P.; Komrokji, R. S.; Klimek, V. M.; Goldberg, J. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Circulating tumor cells (CTCs) N-terminal androgen receptor expression to identify patients (pts) with castrate resistant prostate cancer (CRPC) who are more sensitive to chemotherapy
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Halabi, S.; Carbone, E.; Fernandez, C.; Chen, Y.; Autio, K. A.; Rathkopf, D. E.; Kampel, L.; Morris, M. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save